Newmont Corporation

NEM is in a Stage 2 advancing regime with rising intermediate and long-term trends confirmed by rising 50- and 200-day SMAs. Price has consolidated in a tight range just above the rising 9- and 20-day EMAs near the 52-week high, offering a disciplined pullback entry. Short-term conditions favor execution now with EMAs holding as support and neutral momentum. Primary risks include a breakdown below the 20-day EMA and failure to extend above the 52-week high.

• ↑Record $2.2B free cash flow in Q2 2026, driven by $3.8B from operations
• ↑All-in sustaining costs dropped to $1,621/oz in Q2, underscoring disciplined cost management
• ↓Negative earnings yield and weak earnings revisions signal potential value trap